InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by SHOVLIN ROBERT J., Président des Services Cliniques. Officer active across 1 companies, notably Neogenomics INC. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 25 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€630,43196,167 shares@ €6.55560.059% mcap100.0% of flow
Common Stock
SEC:0001077183-21-000134·
€630,43196,167 shares@ €6.55560.059% mcap50.0% of flow
Common Stock
SEC:0001077183-21-000134:0·
2 of 2 declarations
About SHOVLIN ROBERT J.
Robert J. Shovlin is the President of Clinical Services at Neogenomics Inc. He leads the company's clinical operations, ensuring efficiency and quality of services. His expertise in biotechnology is crucial for developing innovative health solutions.
